Genetically determined severity of anti-myeloperoxidase glomerulonephritis

Hong Xiao1, Dominic Ciavatta, David L Aylor

  • 1Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina 27599, USA.

Insights

Genetic factors significantly influence the severity of myeloperoxidase-antineutrophil cytoplasmic autoantibody-associated necrotizing and crescentic glomerulonephritis. Mouse studies reveal that genetically determined differences in neutrophil function mediate disease severity, likely involving multiple gene interactions.

Area of Science:

  • Immunology
  • Genetics
  • Nephrology

Background:

  • Myeloperoxidase (MPO) is a key target antigen for antineutrophil cytoplasmic autoantibodies (ANCA).
  • MPO-ANCA are implicated in causing necrotizing and crescentic glomerulonephritis (NCGN) and vasculitis.
  • Disease severity in ANCA-associated NCGN exhibits patient-to-patient variability, suggesting a role for genetic factors.

Purpose of the Study:

  • To investigate the genetic basis of MPO-ANCA NCGN severity.
  • To identify genetic loci associated with NCGN severity using diverse mouse models.
  • To elucidate the mechanisms underlying genetically determined differences in disease severity.

Main Methods:

  • Utilized 13 inbred mouse strains, F1 and F2 hybrids, and bone marrow chimeras.
  • Administered anti-MPO IgG intravenously to induce NCGN and assessed severity across strains.
  • Employed high-density genotyping (542,190 SNPs) and quantitative trait loci (QTL) analysis.
  • Conducted in vitro neutrophil function assays and in vivo bone marrow chimera studies.

Main Results:

  • Significant variation in NCGN severity was observed among mouse strains following anti-MPO IgG induction.
  • Genomic analysis identified potential candidate loci for disease severity by comparing phenotypically distinct but genetically similar mouse strains.
  • Absence of a dominant QTL suggests that NCGN severity results from complex interactions among multiple genes.
  • Neutrophil function assays and chimera studies indicated that genetically determined neutrophil function mediates NCGN severity.

Conclusions:

  • Genetic factors play a crucial role in determining the severity of MPO-ANCA-associated NCGN.
  • Differences in neutrophil function, influenced by genetics, are central to the pathogenesis of NCGN.
  • Multiple gene interactions, rather than a single major gene, likely underlie the observed variations in disease severity.